Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy P Lynch

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
American Journal of Physiology. Heart and Circulatory Physiology|January 26, 2019
Activation of Notch signaling by soluble Dll4 decreases vascular permeability via a cAMP/PKA-dependent pathwayRachel Boardman, Vincent Pang, Naseeb Malhi, et al.
Microcirculation (New York, N.Y. : 1994)|June 25, 2026
ZEB1 Modifies VE-Cadherin Signaling in Lymphatic Endothelial CellsNada S Ahmed, Joseph L Horder, Charles T Cresswell, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 30, 2025
The splicing factor kinase SRPK1 is a therapeutic target for peripheral vascular diseaseSohni Ria Bhalla, Mussarat Wahid, Jason O Amartey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2025
Pharmacological blocking of microfibrillar-associated protein 4 reduces retinal neoangiogenesis and vascular leakageAnders Schlosser, Bartosz Pilecki, Claire Allen, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
American Journal of Physiology. Heart and Circulatory Physiology|January 26, 2019
Activation of Notch signaling by soluble Dll4 decreases vascular permeability via a cAMP/PKA-dependent pathwayRachel Boardman, Vincent Pang, Naseeb Malhi, et al.
Microcirculation (New York, N.Y. : 1994)|June 25, 2026
ZEB1 Modifies VE-Cadherin Signaling in Lymphatic Endothelial CellsNada S Ahmed, Joseph L Horder, Charles T Cresswell, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 30, 2025
The splicing factor kinase SRPK1 is a therapeutic target for peripheral vascular diseaseSohni Ria Bhalla, Mussarat Wahid, Jason O Amartey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2025
Pharmacological blocking of microfibrillar-associated protein 4 reduces retinal neoangiogenesis and vascular leakageAnders Schlosser, Bartosz Pilecki, Claire Allen, et al.
Pageof 2